Is LRMR stock safe? | Glauxie AI

Q: Is LRMR stock safe?

Larimar Therapeutics, Inc. (LRMR) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Carole S. Ben-Maimon. Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product... Employees: 20,000.

Q: What are the risks of investing in LRMR?

Identify key risks of investing in LRMR — debt, competition, volatility, and sector headwinds.

Q: Is LRMR a good long-term investment?

Evaluate LRMR as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does LRMR have?

Review LRMR total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is LRMR stock safe?

🦉

Larimar Therapeutics, Inc. (LRMR)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCarole S. Ben-Maimon

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a...

Key Executives

Name	Title
Carole S. Ben-Maimon	Chief Executive Officer, President & Director
Francis Michael Conway	Vice President & Controller
Gopi Shankar	Chief Development Officer
Jennifer Spokes Johansson	Vice President of Legal & Compliance
John Berman	Vice President of Finance & Administration
Michael Celano	Secretary & Chief Financial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

LRMR Profile Financials

What are the risks of investing in LRMR? Is LRMR a good long-term investment? How much debt does LRMR have?